Matches in Wikidata for { <http://www.wikidata.org/entity/Q93077442> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q93077442 description "article scientifique publié en 2019" @default.
- Q93077442 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93077442 description "scientific article published on 15 June 2019" @default.
- Q93077442 description "wetenschappelijk artikel" @default.
- Q93077442 description "наукова стаття, опублікована 15 червня 2019" @default.
- Q93077442 name "Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies" @default.
- Q93077442 name "Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies" @default.
- Q93077442 type Item @default.
- Q93077442 label "Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies" @default.
- Q93077442 label "Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies" @default.
- Q93077442 prefLabel "Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies" @default.
- Q93077442 prefLabel "Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies" @default.
- Q93077442 P1433 Q93077442-A88694BC-0F94-4123-8169-1EFEA2991069 @default.
- Q93077442 P1476 Q93077442-D3ECD4A4-F1BD-484B-BD9F-F12210733CF2 @default.
- Q93077442 P2093 Q93077442-26166282-F043-4FD7-A60B-ACA8C692D0A7 @default.
- Q93077442 P2093 Q93077442-2ADAEF60-9C06-4996-A6BC-E3BA08FE0AB7 @default.
- Q93077442 P2093 Q93077442-35274599-D0A3-4249-B234-8C04E5557333 @default.
- Q93077442 P2093 Q93077442-5346B22B-A711-4C37-98D9-8A0A47023A79 @default.
- Q93077442 P2093 Q93077442-5E570E2C-056F-4F6E-A430-A96AE99E4CB3 @default.
- Q93077442 P2093 Q93077442-61A5B87E-A08A-4F6E-BBDD-C4AFCF8DA3A1 @default.
- Q93077442 P2093 Q93077442-7A46E647-6486-4EE7-BA38-3B3FE5FE2DDC @default.
- Q93077442 P2093 Q93077442-80DED22E-2B08-449A-86A2-06CB18531BB3 @default.
- Q93077442 P2093 Q93077442-8183B601-114D-477D-A738-2852D78F6726 @default.
- Q93077442 P2093 Q93077442-DEE11BB0-7213-40F2-96EE-7D3A8EDA0F07 @default.
- Q93077442 P2093 Q93077442-FCCBD27E-BE11-487F-9EEA-C31B32231887 @default.
- Q93077442 P304 Q93077442-E6AD2D15-829D-4AEC-977B-E4E3E4F22867 @default.
- Q93077442 P31 Q93077442-D3C7F2AA-64B9-4D9E-B344-5601CA8305CF @default.
- Q93077442 P356 Q93077442-8BC1BFC3-9FC0-40E7-9D4B-4633B69C600F @default.
- Q93077442 P478 Q93077442-F75E50CF-C245-4D6E-9E39-0BE98E495402 @default.
- Q93077442 P577 Q93077442-EB332DD1-B7CC-4134-96C0-C583E3D88477 @default.
- Q93077442 P698 Q93077442-0765EEA8-9BFA-4E9A-ADEF-3A2F630923A3 @default.
- Q93077442 P356 J.EJMECH.2019.06.031 @default.
- Q93077442 P698 31247375 @default.
- Q93077442 P1433 Q3008624 @default.
- Q93077442 P1476 "Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies" @default.
- Q93077442 P2093 "Bryan Mackowiak" @default.
- Q93077442 P2093 "Caitlin Lynch" @default.
- Q93077442 P2093 "Dongdong Liang" @default.
- Q93077442 P2093 "Fengtian Xue" @default.
- Q93077442 P2093 "Hongbing Wang" @default.
- Q93077442 P2093 "Linhao Li" @default.
- Q93077442 P2093 "Menghang Xia" @default.
- Q93077442 P2093 "Scott Heyward" @default.
- Q93077442 P2093 "William D Hedrich" @default.
- Q93077442 P2093 "Yong Ai" @default.
- Q93077442 P2093 "Yue Yin" @default.
- Q93077442 P304 "84-99" @default.
- Q93077442 P31 Q13442814 @default.
- Q93077442 P356 "10.1016/J.EJMECH.2019.06.031" @default.
- Q93077442 P478 "179" @default.
- Q93077442 P577 "2019-06-15T00:00:00Z" @default.
- Q93077442 P698 "31247375" @default.